Australia, July 1 -- Resseptor Therapeutics Pty. Ltd., owns the trademark (2500412) for 'Resseptor Therapeutics' till Nov. 20, 2034.
Status: registered:
Registered/protected
Class: 5 [Pharmaceutical preparations for use in the treatment of cancer, autoimmune disease, and immune system-related diseases and disorders; Immunotherapy preparations comprising engineered t-cell receptors; Immunotherapy preparations comprising covalently binding proteins; Immunotherapeutic drugs; Engineered T cell receptors; Covalently binding proteins; Reagents for medical use; Diagnostic reagents for medical use; Diagnostic preparations for medical purposes]
Type of Mark: Word
Date of Acceptance: Jan. 21
Registration Advertised: June 30
For further details contact Resseptor Therapeutics.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2500412.
Disclaimer: Curated by HT Syndication.
